Sfoglia per Rivista VACCINE
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database
2023 Santi Laurini G.; Montanaro N.; Broccoli M.; Bonaldo G.; Motola D.
Reversion to virulence of a subtype B avian metapneumovirus vaccine: Is it time for regulators to require availability of vaccine progenitors?
2014 Cecchinato, M.; Catelli, E; Lupini, C.; Ricchizzi, E.; Prosperi, S.; Naylor, C.J.
Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review.
2006 Jacquet JM; Bégué P; Grimprel E; Reinert P; Sandbu S; Silfverdal SA; Faldella G; Nolan T; Lambert S; Richmond P; Marshall H; Roberton D; Schuerman L.
Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults
2014 Giacomet V.; Penagini F.; Trabattoni D.; Vigano A.; Rainone V.; Bernazzani G.; Bonardi C.M.; Clerici M.; Bedogni G.; Zuccotti G.V.
Safety of DTaP-IPV-HIb-HBV hexavalent vaccine in very premature infants.
2007 Faldella G; Galletti S; Corvaglia L; Ancora G; Alessandroni R.
Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era
2014 Zuccotti G.; Mameli C.; Daprai L.; Garlaschi M.L.; Dilillo D.; Bedogni G.; Faccini M.; Gramegna M.; Torresani E.; Emanuela B.; Annarita B.; Milena B.; Dorella B.; Manuela B.; Simona C.C.; Irene C.M.; Giacomo C.; Laura D.A.; Silvia D.; Francesca D.N.; Massimiliano D.; Erica G.; Vera G.; Grazia G.M.; Franca L.; Barbara L.; Maddalena M.; Elisabetta M.; Gabriella M.M.; Anna M.; Pilar N.; Mariangela P.; Damiano P.; Michela P.; Stefania P.; Norberto P.; Giulia R.; Francesca R.; Riccardo R.; Natascia S.; Vincenzo S.; Giuseppina S.; Maria T.R.; Mariangela T.; Matteo T.; Marta T.; Maurizio V.; Chiara V.
Subpopulations in aMPV vaccines are unlikely to be the only cause of reversion to virulence
2015 Franzo, G; Naylor, C.J.; Drigo, M.; Croville, G.; Ducatez, M.F.; Catelli, E.; Laconi, A.; Cecchinato, M.
A systematic review evaluating the potential for bias and the methodological quality of meta-analyses in vaccinology
2007 DE VITO C; MANZOLI, Lamberto; MARZUILLO C; ANASTASI D; BOCCIA A; VILLARI P.
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy
2009 C. De Giovanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Palladini; A. Antognoli; A. Murgo; M.L. Ianzano; V. Grosso; V. Stivani; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
2013 L. Wijnans;C. Lecomte;C. d. Vries;D. Weibel;C. Sammon;A. Hviid;H. Svanström;D. Mølgaard-Nielsen;H. Heijbel;L. A. Dahlström;J. Hallgren;P. Sparen;P. Jennum;M. Mosseveld;M. Schuemie;N. v. der;M. Partinen;S. Romio;F. Trotta;C. Santuccio;A. Menna;G. Plazzi;K. K. Moghadam;S. Ferro;G. J. Lammers;S. Overeem;K. Johansen;P. Kramarz;J. Bonhoeffer;M. C. J
Two similar commercial live attenuated AMPV vaccines prepared by random passage of the identical field isolate, have unrelated sequences
2019 Laconi A.; Catelli E.; Cecchinato M.; Naylor C.J.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database | Santi Laurini G.; Montanaro N.; Broccoli M.; Bonaldo G.; Motola D. | 2023-01-01 | VACCINE | - | 1.01 Articolo in rivista | Real-life safety profile of mRNA vaccines for COVID-19_ An analysis of VAERS database.pdf; 1-s2.0-S0264410X23003481-mmc1.docx |
Reversion to virulence of a subtype B avian metapneumovirus vaccine: Is it time for regulators to require availability of vaccine progenitors? | Cecchinato, M.; Catelli, E; Lupini, C.; Ricchizzi, E.; Prosperi, S.; Naylor, C.J. | 2014-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review. | Jacquet JM; Bégué P; Grimprel E; Reinert P; Sandbu S; Silfverdal SA; Faldella G; Nolan T; Lambert... S; Richmond P; Marshall H; Roberton D; Schuerman L. | 2006-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults | Giacomet V.; Penagini F.; Trabattoni D.; Vigano A.; Rainone V.; Bernazzani G.; Bonardi C.M.; Cler...ici M.; Bedogni G.; Zuccotti G.V. | 2014-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Safety of DTaP-IPV-HIb-HBV hexavalent vaccine in very premature infants. | Faldella G; Galletti S; Corvaglia L; Ancora G; Alessandroni R. | 2007-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era | Zuccotti G.; Mameli C.; Daprai L.; Garlaschi M.L.; Dilillo D.; Bedogni G.; Faccini M.; Gramegna M....; Torresani E.; Emanuela B.; Annarita B.; Milena B.; Dorella B.; Manuela B.; Simona C.C.; Irene C.M.; Giacomo C.; Laura D.A.; Silvia D.; Francesca D.N.; Massimiliano D.; Erica G.; Vera G.; Grazia G.M.; Franca L.; Barbara L.; Maddalena M.; Elisabetta M.; Gabriella M.M.; Anna M.; Pilar N.; Mariangela P.; Damiano P.; Michela P.; Stefania P.; Norberto P.; Giulia R.; Francesca R.; Riccardo R.; Natascia S.; Vincenzo S.; Giuseppina S.; Maria T.R.; Mariangela T.; Matteo T.; Marta T.; Maurizio V.; Chiara V. | 2014-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Subpopulations in aMPV vaccines are unlikely to be the only cause of reversion to virulence | Franzo, G; Naylor, C.J.; Drigo, M.; Croville, G.; Ducatez, M.F.; Catelli, E.; Laconi, A.; Cecchin...ato, M. | 2015-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
A systematic review evaluating the potential for bias and the methodological quality of meta-analyses in vaccinology | DE VITO C; MANZOLI, Lamberto; MARZUILLO C; ANASTASI D; BOCCIA A; VILLARI P. | 2007-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy | C. De Giovanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Palladini; A. Antognoli; A. Murgo; M.L. I...anzano; V. Grosso; V. Stivani; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini | 2009-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. | L. Wijnans;C. Lecomte;C. d. Vries;D. Weibel;C. Sammon;A. Hviid;H. Svanström;D. Mølgaard-Nielsen;H.... Heijbel;L. A. Dahlström;J. Hallgren;P. Sparen;P. Jennum;M. Mosseveld;M. Schuemie;N. v. der;M. Partinen;S. Romio;F. Trotta;C. Santuccio;A. Menna;G. Plazzi;K. K. Moghadam;S. Ferro;G. J. Lammers;S. Overeem;K. Johansen;P. Kramarz;J. Bonhoeffer;M. C. J | 2013-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Two similar commercial live attenuated AMPV vaccines prepared by random passage of the identical field isolate, have unrelated sequences | Laconi A.; Catelli E.; Cecchinato M.; Naylor C.J. | 2019-01-01 | VACCINE | - | 1.01 Articolo in rivista | Laconi et al IRIS.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile